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This systematic review aimed to determine the effectiveness of nurse-led cancer survivorship care, compared with existing 
models of care, on patient reported outcomes for cancer survivors.  
Methods 
Randomised and non-randomised controlled trials and controlled before-after studies published in English between 1 January 
2007 and 28 July 2017 were identified in bibliographic databases including Medline, Pubmed and PsychINFO. Included studies 
described nurse-led cancer care after treatment to adults (age ≥18 years) <2 years post treatment completion. Risk of bias was 
assessed using Joanna Briggs Institute’s tools and meta-analysis was undertaken. 
Results 
Twenty one publications were included describing 15 tumour-specific trials involving 3278 survivors of breast (n=5), 
gynecological (n=3), head and neck (n=2), colorectal (n=2), upper gastrointestinal (n=2) and prostate (n=1) cancers. Seven trials 
reported quality of life (QoL) using the EORTC QLQ-C30; participants receiving nurse-led care (4-6 months) had better cognitive 
(4 trials, 463 participants; mean difference [MD]=4.04 [95% CI, 0.59 to 7.50]; p=0.02) and social functioning (4 trials, 463 
participants; MD=3.06 [0.14 to 5.97]; p=0.04) but worse appetite loss (3 trials, 354 participants; MD=4.43 [0.08 to 8.78]; p=0.05). 
After intervention completion, intervention participants had reduced fatigue (4 trials, 647 participants; MD=-4.45 [-7.93 to -0.97]; 
p=0.01). 
Conclusion 
This systematic review synthesised outcomes of models of nurse-led survivorship care and contributes a meta-analysis of 
patient QoL to survivorship evidence. This review was limited by the risk of bias in many included studies for blinding of 
treatment personnel and outcome assessors. Nurse-led care appears beneficial for cancer survivors for some QoL domains.  
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Advances in cancer care over the past three decades have led to dramatic improvements in survival rates with more than 66% 
of Australian cancer patients now surviving more than five years [1]. Multi-modal therapies are associated with numerous 
challenges for individuals who live with complex and debilitating side effects, that can interfere with wellbeing and quality of life 
(QoL), and disease-related problems [2]. These may include physical, psychological, social and existential needs manifesting as 
anxiety, fear of recurrence and uncertainty about the future; social isolation [2]; treatment effects including fatigue, sterility and 
loss of sexual function [3]; financial hardship and risk of second cancers and cardiovascular disease [4]. Cancer services in their 
current form may no longer have the capacity to provide care for the growth of patients who survive a cancer diagnosis, which in 
Australia will result in a projected overall increase of approximately 23-58% in the number of years lived with ill health or 
disability [5]. This has led to increased interest in nurse-led models of cancer survivorship care because of the opportunity to 
utilise advanced nursing roles and potential advantages over traditional follow-up including improved efficiency, quality of care 
and reduced costs [6]. This systematic review aims to determine the effectiveness of nurse-led cancer survivorship care compared 
with existing models for survivors who were diagnosed with cancer as adults (age ≥18 years) and who are <2 years post treatment 
completion. 
Comprehensive care for cancer survivors includes monitoring of: cancer spread; recurrence or second cancers; late effects or 
long term psychosocial and physical problems; preventative health; oral and dental health; legal and employment issues; and 
financial concerns [7]. The survivorship phase should involve reframing the patient's life which has been disrupted by cancer and 
the restoration of personal meaning. This can be guided by the International Classification of Functioning, Disability and Health 
(ICF) framework which defines health and health-related well-being domains according to function and restrictions from the 
perspective of the body, individual and society [8]. Providing information across the cancer continuum is an important aspect of 
care; it promotes coping and self-management and reduces anxiety, and, yet it is a frequently reported unmet need [9]. There is 
growing level I and II evidence for integration of healthy lifestyle behaviours as prevention strategies into routine care of patients 
with cancer [10-13]. It has been recommended that a written survivorship care plan and treatment summary are provided at the 
transition from the specialist to the survivorship program [14,15]. Recent evidence demonstrates that treatment summaries and 
care plans provided to patients with a verbal explanation lead to improved self-efficacy in patients more than 2 years from 
diagnosis, which is associated with a significantly lower risk of emergency presentation and hospitalisation [16]. 
A model of care defines the best practice, based on available evidence, for a group of patients with a particular disease 
including the care services and activities that should be provided at each stage, their location and health professionals who can 
best provide care [17]. Optimal care pathways (OCCP) are tumour-specific guides to best cancer care, recently endorsed 
nationally in Australia, which outline the critical steps in the care of a patient diagnosed with a particular cancer [18]. After initial 
treatment and recovery the OCCP describes the lead health care professional's role, although the profession is not stipulated. The 
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Clinical Oncology Society of Australia (COSA) [15] defined critical components of a wellness model of cancer survivorship care 
as: survivor-centred; initiated at diagnosis; integrated across service levels at each stage; coordinated; promotes well-being; 
prevents illness; and has accessible and equitable care. In the COSA model care is directed by a needs assessment at diagnosis and 
on transition to follow-up. In addition, care is stratified after risk assessment for: disease related comorbidities and recurrence; 
treatment sequelae; existing comorbidities; and survivor ability and motivation to self-manage. A number of models of cancer 
survivorship care described in the literature are based in hospitals/cancer centres or the community and are led by: cancer 
specialists, nurses, family physicians, patients (self-managed) or shared care (two or more clinicians of different specialties) [19].  
From a historical perspective, development and implementation of nurse led models of care has been varied and not well 
documented. Prior to the introduction of the first nurse-led models of care, advanced practice nursing roles had been developing 
for over twenty years (up to the late 1990s) in recognition of the need for nurses to extend their practice [20]. In 2003 Corner [6] 
reviewed the first nurse-led care models which were for chronic disease, highlighting that nursing roles at that time largely 
functioned within a restricted delegation model rather than a comprehensive advanced practitioner model. Corner reviewed 
emerging evidence for nurse-led care in cancer management through identification of a handful of studies. Although there is lack 
of clarity about what constitutes a nurse-led model of care [21,22] the following definition by Albarran (2005) is applied in this 
review “…in this model, a nurse is responsible for the overall co-ordination, management and continuity of care for a specific 
episode of treatment or intervention” [23]. A systematic review of qualitative studies identified key areas of patients' subjective 
experience of nurse-led clinics as being: therapeutic relationships enhanced by nurses' interpersonal skills and holistic approach; 
effective health communication, language and methods that meets patients' needs and health literacy levels, enabling patients' 
independent decisions; respect for specialist nurses' high level of clinical and medical knowledge; and patient-nurse collaboration 
empowering patients self-care and management [24]. Our recent work demonstrated that patients who received care from an 
experienced Cancer Nurse Coordinator (CNC) experienced a more coordinated patient journey and health professionals viewed 
the CNC role as a focal point of contact throughout the patient care trajectory; coordinating all aspects of patient care; providing 
patient education and information; and being reliable and accountable [25]. Reported barriers to implementation of nurse-led 
models of care include: funding and resource implications; developing service capacity to meet demand; time required to meet 
demands of a comparatively onerous audit culture; and lack of visibility and referrals [26]. 
Studies of nurse-led models of cancer follow-up have been conducted in the following cancer populations: prostate, colorectal, 
ovarian, oesophageal, breast, head and neck, mixed and lung [27-33]. Compared with physician-led follow-up, nurse-led follow-
up was found to have comparable safety, adequate detection of cancer recurrence, equivalent health related QoL and patient 
satisfaction, reduced medical-specific costs, and similar overall costs [6,27]. Given the increasing interest in nurse-led models of 
care and recognition of the importance of cancer survivorship care, this systematic review aims to identify, review and synthesise 
publications which evaluated nurse-led models of cancer survivorship care. Specifically, the objective was to determine the 
effectiveness of nurse-led care compared with existing models of care for cancer survivors who were diagnosed with cancer as 
adults (age ≥18 years) and were <2 years post treatment completion.   
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Method 
This review followed Cochrane methodology [34] and used Joanna Briggs Institute’s critical appraisal tools [35] to assess risk 
of bias in included studies.  
Studies 
This review included randomised controlled trials (RCTs), non-randomised controlled trials (NRCTs) and controlled before-
after (CBA) studies. Only studies published in English were included. 
Participants 
Studies were included if participants were adult cancer patients (aged ≥ 18 years) who were <2 years post cancer treatment 
completion. 
Interventions 
We included studies which evaluated cancer nurse-delivered cancer care, of any frequency or duration, for patients who 
completed cancer treatment <2 years previously. The type of care included: monitoring; treatment and/or referral for recurrence; 
or assessment and treatment for side effects of treatment or QoL needs including physical, psychosocial, functional, financial, 
insurance, occupational, fertility, sexual function, sexuality and spiritual needs. Included studies compared the intervention with 
standard follow-up care for the tumour type in any treatment setting, for example delivered by a specialist or general practitioner, 
in a primary care or acute hospital setting. 
Outcomes 
The main outcomes reviewed were patient reported outcomes (e.g. physical and psychosocial symptoms) and other QoL 
indicators; resources (human, financial, time, and healthcare facilities) used; and benefits and shortcomings of the model of care 
for patients, health professionals and/or the health system. Also considered were: tumour types; key components of the 
intervention/nurse's role; patient inclusion criteria; timing of introduction during the treatment continuum including duration and 
frequency; and whether a survivorship care plan and/or treatment summary was included. Each model of care was assessed in 
terms of the critical components of a wellness model of cancer survivorship care outlined by COSA [15]. 
Identification of studies 
Studies published between 1 January 2007 and 28 July 2017 (previous 10 years) were identified through searches of the 
following bibliographic databases: Medline, Pubmed, PsychINFO, Scopus, Psychology & Behavioural Sciences Collection, 
Informit (Health Collection), CINAHL and PsychARTICLES. Our pre-study scoping for this study revealed there were few 
rigorously evaluated nurse-led cancer services published before our search date range which utilised a comprehensive advanced 
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practitioner model [6] and the definition of what constitutes nurse-led care was inconsistent [23]. Since then, nurse-led care has 
evolved [27] and our intention was to include interventions which would best fit with current nursing roles and be applicable to 
current health services. Evidence-based practice and clinical practice guideline databases were also searched: JBI Connect, 
Worldviews on Evidence-based Nursing, Database of Abstracts of Reviews of Effects and Cochrane Library of Systematic 
Reviews. The following were hand searched: Nursing Research Journal; National Institute for Health and Care Excellence; 
National Guideline Clearinghouse and NHMRC Clinical Practice Guidelines Portal Australia. Keywords were selected from 
relevant publications and additional keywords were found by searching the Medical Subject Headings database 
(http://www.ncbi.nlm.nih.gov/). The search strategy was tested and the final strategy and keywords were decided by the research 
team (Table 1). Both spelling variations of tumour (tumor) were included in searches of all sources, apart from JBI Connect, in 
which the 'tumor' variant was inadvertently omitted; this is an Australian resource, a language in which the ‘tumour’ spelling is 
used, which provided a small proportion (6%) of our total search results; later testing revealed that adding the ‘tumor’ variant 
would only have resulted in an approximate and negligible 2% change to results. Depending on database functionality, truncation 
and wildcard searching were allowed and limits to English language and human studies were applied.  
Data collection 
A total of 8824 results were obtained from bibliographic databases. Following removal of a large proportion of duplicates 5077 
articles were included. Of these, 4355 citations were excluded based on the title and 722 abstracts were screened. One hundred 
and seventy-six full-text articles were retrieved and further assessed for eligibility. Of these 21 articles met the inclusion criteria. 
A total of 155 articles were excluded for reasons shown in Figure 1 which describes the data evaluation phase using the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses [36]. Three papers, which otherwise met inclusion criteria, were 
excluded because two were earlier precursor trials or feasibility tests of included studies and for one paper we were unable to 
assess methodological quality of study processes due to lack of clarity in the final published paper. Abstracts or dissertations were 
excluded. One reviewer independently selected relevant titles and abstracts (MB), and all problematic decisions were discussed 
with a second reviewer (LM). Both reviewers confirmed the final list of included papers met the inclusion criteria. The reference 
lists of included studies were searched for suitable articles and relevant titles underwent the same review process described.  
Outcome measures data described above, along with publication information, study characteristics, participant information, key 
components of the nurse-led intervention, and main findings, were extracted from each included paper by one reviewer (MB) and 
were checked by a second reviewer (LM). Risk of bias of included studies were independently assessed by two reviewers (LM, 
MB) by use of Joanna Briggs Institute’s critical appraisal tools for RCTs and Quasi-Experimental Studies [35] and discrepancies 
were resolved by discussion.  
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Data synthesis 
The narrative synthesis presented findings where three or more included studies measured conceptually similar outcomes and 
included: quality of life and psychological measures; symptoms; patient satisfaction; and economic measures. RevMan (Review 
Manager version 5.3.5) [37] was used to conduct meta-analyses where three or more studies had used the same instrument and 
reported a group mean, standard deviation and sample size. Seven studies used the EORTC QLQ-C30 instrument (four reported 
all sub-scales) and three used the CES-D; both instruments report continuous data. Because the timing of intervention initiation 
relative to cancer treatment and intervention duration varied across studies, all outcomes were categorized based on time since the 
start of the intervention which was treated as a sub-group in the analysis: during the intervention up to 3 months, 4-6 months and 
7-23 months, and after completion of the intervention. Studies which reported measurement times in terms of time since baseline 
were realigned relative to intervention start and if baseline measures occurred during a long recruitment period, the median time 
between baseline and intervention start was used to re-align the data. Where studies used repeated measurements within a defined 
time period, the data was averaged within groups. For each study reporting findings for the specified domain within the time 
period, the mean difference between intervention and control groups and 95% CI was calculated. A random effects inverse 
variance model was used. Pooled results by time period and individual results are presented using forest plots. Heterogeneity was 
determined using the Chi2 test (p<0.10) [38] and the I2 statistic (0-30% low, 30-50% moderate, >50% substantial) [38,39]. For 
reasons of brevity, only meta-analyses with a significant overall effect test at any time period are presented in this paper. The 
corresponding author can be contacted regarding the remaining non-significant meta-analyses.  
Results 
Description of included studies 
Twenty one [30,40-59] publications described 15 interventions of nurse-led models of care for cancer survivorship. Extracted 
data are presented in Supplement 2; six publications [44,50,51,53,55,56] were secondary analyses of included trials (e.g. 
economic, rural or a long term time point) and their findings are considered together with the original publication in this review 
and are reported in the same table row. Twelve studies were RCTs, two were CBA studies and one was a randomised case-control 
study. The interventions were compared to physician-led follow-up [41,46,48,57,58], conventional nursing care [47,54], usual 
multi-disciplinary hospital care [43], no intervention [42] or usual care (provider not described) [30,45,59]. Some comparison 
groups consisted of “attention control”, with referral to physicians if needed [40,49], or attention control in addition to multi-
disciplinary care [31].  
Participant characteristics 
Total sample sizes of studies ranged from N=70 [40] to N=756 [59]; most studies had two groups of equivalent size, apart from 
one study with 3 groups (2 experimental, 1 control) [54] and one 2x2 factorial design RCT [43]. The average age of participants, 
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reported for the total sample or each study group separately, ranged from 46.1 to 70.2 years. Details of anticancer treatment varied 
in each study and are shown in Supplement 2. Eligible participants in the majority of studies (12 of 15) had received surgical 
treatment with or without chemotherapy or radiation therapy. No studies reported patients had received immunotherapy. 
Description of interventions 
Models of care were tumour-specific and for adult survivors with the following cancers: breast [42,43,45,52,54], gynecological 
[40,47,49], head and neck [41,57], colorectal [30,59], oesophageal or gastric cardia [48,58] and prostate [46]. Two interventions 
commenced during surgical inpatient treatment and provided preoperative, postoperative and discharge care for gynaecological 
cancer patients with follow-up at home [40] or discharge care for oesophageal and gastric cardia cancer patients with telephone 
follow-up [48]. Of the remaining interventions, the majority commenced after treatment completion [30,41-43,46,47,52,57-59], 
while in three studies care began during outpatient treatment [45,49,54]. Care settings and/or modalities included: an outpatient 
setting [42,57]; both outpatient and telephone follow-up [30,41,52]; telephone follow-up [45,46,48,54,59] with optional outpatient 
clinic visits [43]; both telephone follow-up and home visits [47,49] or only home visits [58]. Most interventions continued for 6 
months [46-49,52,54,59], or continued for either 3 months [30,40], 12 months [41,57,58], 18 months [43], up to 5 years [45] or 
involved only one consultation after treatment [42]. Almost all followed a planned follow-up schedule of predominantly evenly 
spaced visits [41,43,46,47,52,54,57]. However, some initially required frequent visits which reduced in frequency over time 
[30,48,49,59]. The interventions frequently involved six visits [41,46,54,57,58], or less [30,40,42,43,59] however, one involved 
eight visits [52] and three involved more than 12 visits [47-49]. One had an open access model and the average number of patient 
contacts was not reported [45]. 
The qualifications and experience of nurses were incompletely described across studies. Nurses were generally described as 
either oncology nurses or an advanced practice nurses, or sometimes both (Supplement 2). In a number of studies nurses were 
trained for delivery of the intervention [30,41,43,52,57-59]. In the majority of interventions, nurses provided the following three 
elements of care: patient assessment, general management of a problem and patient education or advice 
[30,40,41,43,45,46,48,49,52,57,59] while others provided one or two elements [42,54,58]. A few interventions included discharge 
planning [40,43,48] with several designed to promote well-being and prevent illness [30,42,45,47-49,52,54], or well-being alone 
[57,59]. Nurses made referrals to other health care providers [41,46,48,49,58] or ordered and/or reviewed tests [43,45] in some 
models of care. A patient manual or resource was used in five survivorship models of care [30,40,42,45,52].  
Many models of care included some of the recommended features of survivorship care such as individualised care 
[30,41,43,45,46,48,49,52,57-59] and patient self-management [40,43,45,49,52,54,59]. Inclusion of the following elements of 
survivorship care was less frequently observed: integration of care across service levels [40,45,46,58,59]; coordinated care 
[46,48,49,59]; survivorship care plans and treatment summaries [30,42] and risk stratification [45,46,49]. Some issues regarding 
whether care was accessible or equitable were identified with almost all studies, likely related to the constraints of conducting a 
randomised controlled trial. Examples included the exclusion of patients with: higher grade, non-primary, or metastatic cancers; 
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co-morbidities/disabilities; cognitive impairments; psychiatric illnesses/mental health conditions; illiteracy; or limited travel or 
phone access.  
Description of outcomes 
Aside from one study, all included a QoL measure as an outcome [30,41-43,45,47-49,54,57-59], or a cancer survivorship-
specific QoL measure [40,52] for example, Quality of Life Scale/Cancer Survivors (QOL-CS). Most studies measured symptom 
outcomes, either tumour-specific [30,41,45-48,57,58] or more common cancer-related symptoms [42,49]. Some studies assessed 
patient anxiety [30,43,45,57], depression [30,42,45,49,57], distress [30,46,49,54,59], coping [54,57] or perceived stress [54]. In 
addition, three studies [43,49,54] measured more specific psychological measures e.g. affect regulation. Other survivorship 
outcomes included unmet needs or problems [30,42,59], cancer care coordination [59] and health literacy or perceived 
information provision [42,48]. A few studies measured family function, social constraint or support outcomes, or psycho-social 
adjustment [41,47,54,57] and three studies measured patient satisfaction [30,42,46]. 
Risk of bias 
The assessment of risk of bias in each study is shown in Figure 2. All studies were rated as having a high or unclear risk of bias 
for blinding of treatment personnel which is a probable consequence of the interventions being delivered by an alternative 
provider. Whether outcome assessors were blinded was not addressed in almost all studies, resulting in a predominantly unclear 
risk for this item. As patient reported outcomes were the primary outcomes in the included studies, whether outcomes were 
measured reliably was not applicable to most studies and there was low risk of bias in relation to whether outcomes were 
measured in the same way for all groups.  
Effects of interventions 
Quality of life 
The duration and timing of interventions and outcome measurements varied between studies with many studies measuring 
outcomes at multiple times including at baseline, during the intervention period through to completion and post-completion 
follow-up. This review therefore considered findings in terms of four time periods: during the intervention up to 3 months 
[40,43,48,49,52,55,58,59], 4-6 months [41,45-49,52,55,58,59] and 7-23 months [43,45,55], and after completion of the 
intervention [30,41,42,54,55,58]. Three studies reported group effects with other factors included in the analysis such as time in 2 
way ANOVAs [54] or mixed effect regressions [49], or age in nested models [45].  
In studies which measured QoL or specific domains, there were no significant differences between groups when measured 
during the intervention from 0 to 3 months and 4-6 months in: physical [41,48,58,59], emotional [41,43,48,58,59], role 
[43,48,58,59], social [41,48,58,59] and overall QoL [41,43,48,58,59]. Two studies measured QoL during the intervention (7-23 
months), one demonstrated a beneficial intervention effect on physical and emotional function [55], while the other demonstrated 
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no effect on emotional function and did not report physical QoL [43], and neither demonstrated an effect of the intervention on 
role or social function [43,55]. Three studies demonstrated a beneficial intervention effect when measured after its completion for 
overall QoL [41,47,55], physical [41], emotional [47,55], role [41,55], or social QoL domains [41,47]. Adverse intervention 
effects were less frequently demonstrated; one study found an effect in the QoL role domain when measured after the intervention 
[47]. Three studies investigated QoL outcomes in terms of change over time and found no significant differences between the 
experimental and control groups [45,49,54], but found significant effects of time [49,54] or a significant predictor of patient age 
[45]. Of the two studies which measured cancer survivorship-specific QoL during the intervention [40,52], both demonstrated a 
significant benefit of the intervention for overall QoL, and psychological and social domains. One study demonstrated beneficial 
effects of the intervention for physical and spiritual QoL domains [40] whereas the other showed no intervention effect in these 
domains [52]. 
Most studies found no difference between groups for psychological distress levels at any time period [30,41,46,59] or group 
differences with time included as a factor [54]. In studies which measured anxiety, no group differences were demonstrated at any 
time period [30,43,45,48]. Findings for depression were mixed. One intervention showed benefit during (approximately 10 
months) and shortly after completion of the intervention but this difference was not sustained at longer term follow-up 
approximately 10 months later [55,57]. Another study found no group differences for depression following the intervention (3 
months) or at long term follow-up (6 months) [42]. One study demonstrated significantly higher depressive symptoms in patients 
who received the nurse-led intervention during the intervention (6 months) [49]. 
Symptoms and patient satisfaction 
The following outlines specific QoL domain outcomes reported in three or more studies. Of studies which reported pain 
domain outcomes, no effect was found during the intervention when measured up to 3 months [48,58] or 4 to 6 months [41,48,58] 
however one study demonstrated that intervention participants experienced less pain at 7 to 23 months [55]. After completion of 
the intervention findings were mixed; two studies demonstrated a benefit to the intervention group [41,55] and three studies found 
no effect [30,58]. There were no significant differences in pain symptoms between groups when analysed in nested models with 
age included [45]. No effect of the intervention was demonstrated for any sexuality domains when measured during the 
intervention at up to 3 months [59], 4 to 6 months [41] or 7 to 23 months [55]. After the intervention, most studies found no effect 
of the intervention on sexuality [30,41,45,46,55] however, one demonstrated a benefit [47]. Several studies investigated body 
image however, no significant differences between groups at any time were reported [30,45,48]. In studies which measured unmet 
needs, including survivorship-specific measures, one study found reduced health worry in the intervention group post intervention 
[42] and two found no significant group difference during or after completion of the intervention [30,59]. One study found a 
significant benefit for the intervention in relation to patient satisfaction [30], another study found no difference [53] and another 
study showed increased satisfaction for spouses only [58] . 
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Economic analyses 
Three studies undertook economic evaluations or assessed economic implications. Two studies which substituted nurse-led 
care for usual care found cost reductions. Polinder et al [53] found costs of nurse-led visits were significantly less than standard 
visits (€234 versus €503; p<0.001). The average cost of nurse-led follow-up was lower than standard care (€2592 versus €3798; 
p=0.11) even though more patients in the nurse-led group attended all five protocol visits (82% vs 60%; p=0.002) [53]. Kimman 
et al [44] found that nurse-led telephone follow-up with group education was most cost-effective for mean annual costs (€3 971, 
95%CI, 2975–5186) and had the second highest mean quality-adjusted life years (0.772, 95%CI, 0.745–0.797; highest 0.776, 
95%CI, 0.753-0.799) of the strategies tested. McCorkle et al found that significantly fewer patients who received the nursing 
intervention had one or more primary care visits (mean=2.75 (S.D.=2.03) vs 3.59 (S.D.=4.66)) during 6 months post-surgery 
however, the related costs were not reported [50]. 
Quality of life meta-analysis 
Four significant mean differences between groups were found by meta-analysis, all were in domains of the EORTC QLQ-C30. 
During the intervention (4-6 months) in the intervention group, cognitive functioning was significantly higher by 4.04 units on 
average (MD=4.04, 95%CI [0.59, 7.50], 463 participants, p=0.02; I2=24%; Figure 3) and social functioning was significantly 
higher by 3.06 units on average (MD=3.06, 95%CI [0.14, 5.97], 463 participants, p=0.04; I2=0%; Figure 4). Appetite loss during 
the intervention (4-6 months) was significantly lower in the control group by 4.43 units on average (MD=4.43, 95%CI [0.08, 
8.78], 354 participants, p=0.05; I2=0%; Figure 5). After the intervention, symptoms of fatigue were significantly reduced in the 
intervention group by 4.45 units on average (MD=-4.45, 95%CI [-7.93,-0.97], 647 participants, p=0.01; I2=15%; Figure 6).  
Discussion 
This systematic review of literature published over a ten year period found 15 RCTs and CBA studies of nurse-led models of 
cancer survivorship care for patients with breast, gynecological, head and neck, colorectal, oesophageal or gastric cardia or 
prostate cancer, and who were within two years of treatment completion. The majority of nurse-led survivorship interventions 
commenced after treatment completion and continued for 6 months with a planned schedule of 6 or less evenly spaced visits. Care 
settings and intervention modalities varied and included outpatient, telephone, home or a combination of settings. Nurses were 
generally described as either oncology nurses or advanced practice nurses, or sometimes both, although this was incompletely 
described across studies. In most models of care, the nurse’s role included at least two of the following elements: patient 
assessment, general management of a problem, and patient education or advice. Some recommended features of survivorship care 
[15] were delivered such as individualised care, patient self-management, illness prevention and well-being promotion however, 
other recommended elements were less frequently observed. 
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Almost all studies assessed QoL and most studies measured tumour-specific or common cancer-related symptom outcomes. 
Several also included psychological measures and some evaluated unmet needs, care coordination, health information and patient 
satisfaction. Generally, within studies, there were few significant differences between the control group and the nurse-led care 
group for most measures. Some studies demonstrated a benefit of nurse-led survivorship care post intervention completion on: 
emotional [47,55], physical [41], role [41,55], social [41,47] and global QoL [41,47,55]; pain [41,55]; sexuality [47]; and 
depression [55]. During the intervention, benefits of nurse-led care were found for emotional and physical QoL [55], and 
depression [55] and pain [55]. These findings were predominantly from two studies [41,55] which were notable for being the two 
head and neck tumour models of care, both of 12 months duration with 6 visits.  
Meta-analysis of the EORTC-C30 scale scores synthesised the results from seven studies and found higher cognitive and social 
functioning in patients who were receiving the nurse-led survivorship intervention (4-6 months). Post intervention completion, 
patients who had received the nurse-led survivorship care intervention had significantly reduced fatigue symptoms. Although a 
number of previous reviews have focused on nurse-led models of survivorship care [27,60,61], this is one of the first known meta-
analyses of patient QoL outcomes after nurse-led survivorship care. The finding that nurse-led care provides a benefit to cancer 
survivors in terms of cognitive and social QoL is an important contribution which suggests cancer nurses can assist survivors 
adjust to life after treatment and nurse-led care results in reduced fatigue symptoms for cancer survivors in the longer term. 
One deleterious effect of nurse-led interventions found by meta-analysis was appetite loss (4-6 months) that was significantly 
lower in the control group. Half of the weighting for this sub-group analysis was attributed to head and neck, esophageal and 
gastric cardia models of care. Side effects from these tumour groups and their treatment impact on appetite [62,63] and it is 
possible the interventions improved patients' abilities to identify and report symptoms of appetite loss as a consequence of nurses 
focusing care on these symptoms. Alternatively, this finding could indicate that nurse-led care during treatment does have a 
deleterious effect on appetite loss possibly through inappropriate or insufficient management of symptoms impacting on appetite. 
This would highlight a need for further nursing education, and/or referral to specialist health professionals such as dietitians or 
nutritionists to more appropriately support patients' symptoms of appetite loss. Post intervention completion, appetite loss scores 
were not significantly different in the meta- analysis; scores were evenly weighted from studies with participants with head and 
neck and colorectal tumours. Future research should explore these effects on appetite loss or malnutrition in patients who 
experience nurse-led models of survivorship care; qualitative nursing research may provide areas for future investigation of this 
issue. Two individual studies did report significantly worse scores in the intervention group for depression during the intervention 
(4-6 months) [49] and role functioning QoL post intervention [47]. Both evaluated nurse-led survivorship care for gynaecological 
cancers and one study had a number of concerns related to unclear or high risk of bias [49]. 
Apart from the meta-analysis and other significant findings discussed, there were no significant differences between the control 
and nurse-led care group for most measures. Although this suggests outcomes from nurse-led models of cancer survivorship care 
are not inferior to standard care, this conclusion cannot be drawn as the randomized controlled trials were not designed to 
demonstrate non-inferiority. Future prospective studies would need to determine the non-inferiority margin for death, recurrence, 
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symptoms or QoL outcomes, for which this meta-analysis may provide some guidance, and would require a larger sample size due 
to the smaller margin and higher study power required [64].  
As well as providing a benefit to patients, interventions should be sustainable and economically viable through a measurable 
reduction in costs, reduced workload and demand on current services. Although few studies included an economic analysis, the 
general hypothesis that nurse-led care substituted for usual care can be cost effective, neutral, or reduces health service utilisation 
appeared to be supported [44,53]. Some studies required multi-disciplinary team input for development of evidence based 
algorithms [41,46,59] or patient resources [30,45,49,52,55] and ongoing input may be required for their maintenance. Many 
interventions were supplementary to usual care and therefore would have financial and resource implications [30,41,47,48,55,59], 
whereas others may be practically difficult to implement routinely, in particular the multi-faceted home-based health promotion 
program by Li et al. [47].  
Potential deficits in the construct of the nurse-led models of care were observed by this systematic review. Some interventions 
provided support for patients to meet financial needs [41,42,45,48,52,55], occupation and/or insurance needs [30,42,45,52,55]. 
These needs have been identified as important areas of survivorship care [65,66] and in cancer care, the impact of financial 
toxicity for patients has been recently acknowledged [67]. Interestingly, despite consistent recommendations and recent evidence 
supporting their use [14,16], only two included interventions provided survivorship care plans and/or treatment summaries to 
patients [30,42]. 
Limitations 
We acknowledge this review was limited by the focus on English articles and the omission of unpublished data. Therefore 
findings may reflect a publication bias. However, many studies appeared to have multi-disciplinary stakeholder investment which 
could potentially have improved the likelihood of publication regardless of findings. The meta-analysis strengthened findings of 
this review however we observed that three of the four significant findings included data from the same four publications due to 
the limited number of papers which used the EORTC-QLQ instrument in the time period analysed; this may have biased results 
however the studies used diverse tumour groups (n=2 gastric; n=1 head and neck, and n=1 breast). An exploratory literature 
search identified that a number of randomised controlled trials of nurse-led models of cancer survivorship care are currently 
underway [68-71]. As more data is published this meta-analysis should be repeated to verify the findings. Our literature search 
omitted some broad models of care terms, such as patient engagement, patient empowerment and patient activation, which should 
be considered in future reviews. However we propose the scope of our search terms enabled identification of the majority of 
relevant studies that used such methods. 
Conclusion 
This systematic review identified 15 RCT or CBA evaluations of nurse-led cancer survivorship models of care and presented a 
meta-analysis. The tumour-specific models of care for a variety of tumours were generally introduced after treatment completion 
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with a planned schedule delivered over 6 months and provided patient assessment, clinical management of a problem, education 
or advice, individualised care, and supported self-management. Meta-analysis found a significant benefit to survivors who 
received nurse-led care for cognitive and social QoL, and fatigue; however control patients reported significantly lower appetite 
loss symptoms. This comprehensive systematic review provides a synthesis of nurse-led models of survivorship care, describes 
the patient outcomes compared with usual follow-up and contributes a meta-analysis of patient QoL outcomes to survivorship 
research. Role delegation to nurse-led survivorship care appears to be reliable and feasible, and shows good performance 
compared to standard approaches. A multi-disciplinary setting which provides comprehensive survivorship care, through access to 
other specialist non-physician providers, may be a necessary component of nurse-led models of care. As more RCTs are 
published, the meta-analysis of QoL findings should be repeated to confirm these findings and future studies of nurse-led models 
of survivorship care should consider appropriate study designs and measures to ensure applicability and transferability of findings. 
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Figure titles 
Figure 1 Search results and screening for nurse-led cancer survivorship models of care reported using the PRISMA. 
 
Figure 2 Risk of bias summary: review authors' judgements about each risk of bias item for each study included in the meta-
analysis of PROMs. NRCT - Item only applicable to non-randomised controlled trial. 
 
Figure 3 Forest plot of comparison of cognitive function quality of life, measured by European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in 
studies of nurse- cancer survivorship care. 
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Figure 4 Forest plot of comparison of social function quality of life, measured by European Organisation for Research and 
Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in 
studies of nurse- cancer survivorship care. 
 
Figure 5 Forest plot of comparison of appetite loss symptoms, measured by European Organisation for Research and Treatment 
of Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in studies of 
nurse- cancer survivorship care. 
 
Figure 6 Forest plot of comparison of fatigue symptoms, measured by European Organisation for Research and Treatment of 
Cancer Quality of Life Questionnaire (EORTC-QLQ), in cancer survivor intervention and control participants in studies of nurse- 
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Table 1 Search categories and terms for nurse-led models of cancer survivorship care. Keywords were truncated according to database settings to allow for multiple endings 
for these words. The “or” operator, or equivalent according to each database, was used between the search terms within each category i.e. cancer, survivorship, models of care 
and nursing. The “and” operator, or equivalent, was used to combine the categories of search terms into one search. 
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life after cancer 
life after cancer care 
living with cancer 







continuity of patient care 
follow up studies 
health care 
healthcare 





model of care 
oncology model 
optimal care pathway 
optimal pathway 
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patient care planning 
patient education 




survivorship care plan 
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care and discharge 
teaching (DT) in line 
with the Nursing 
Care Plans. Home 
care visits of 60-90 
minutes in 1st and 
12th week post-
discharge (wound 
care, drug and pain 
management, 
































• Intervention group had lower “loss of sexual attractiveness” 
and “deficient/defective feeling” about body image (p<0.05). 
• Intervention group had higher QoL, and higher physical, 
social, psychological and spiritual well-being (p<0.05). 
• Physical problems in the intervention group were observed 
to be half of control patients: abdominal distension, 
immobilization, insomnia and fatigue (p<0.05). 
• Fatigue was the most important problem affecting physical 
health in both groups. 
• Family stress and sexuality were the most important 
problems affecting the social well-being in both groups. 


















Oncology RNs with 
mean 11 years’ 
experience (6-20) in 
head and neck 
oncology. Trained for 
intervention (8 hours) 
with 3-monthly 
clinical supervision 


























Head & Neck 
Module 
• The intervention group demonstrated significantly poorer 
adjustment at baseline in the following sub-domains of the 
PAIS-SR: health-care orientation, social environment and 
total adjustment (p<0.05). At 6 months, there were no 
differences between the groups. At 12 months, the 
intervention group had poorer adjustment in health-care 
orientation (p<0.02). 
• Change in baseline PAIS-SR was compared between 
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Six 30 minute face-
to-face follow-up 
consultations with 
nurse, following a 
standardised 
protocol, in parallel 
and preceding 
medical routine visits. 
Included a needs 
assessment based 
on the bio-psycho-








































intervention group had significant worse scores at baseline 
(p<0.05) but a 7.8-point (95 % CI=2.3, 13.2, p<0.01) and 
6.7-point (95 % CI=1.3, 12.2, p<0.02) larger improvement 
than the control group at 6 and 12 months, respectively. 
• Clinically relevant changes in PAIS-SR (≥ 1 S.D.): equal 
numbers of patients in both groups had improved by at least 
1 standard deviation at 6 and 12 months; at 6 months, more 
patients had deteriorated in the intervention group than in 
the comparison group, the largest difference was in the 
social environment domain, with twice as many deteriorated 
patients in the intervention group as in the comparison 
group (27 vs. 13 patients, respectively); at 12 months, the 
number of deteriorated patients was approximately equal 
between groups.  
• For EORTC scales, baseline mean scores were significantly 
worse (p<0.05) for the intervention group. At 6 and 12 
months, the mean scores were not significantly different 
between groups and changes from baseline at each time 
point were significantly larger for the intervention group for 
global health status/QOL, 3 of 5 functional scales, 6 of the 9 
generic symptom scales, and 9 of 18 specific head and 
neck scales. 
• Clinically relevant changes in EORTC scales (≥ 10 points) 
for at least 10 more patients in the intervention group 
compared with the control group was observed for: global 
health status/QOL, 3 of the 5 functional scales, 3 of the 9 
generic symptom scales, and for 11 of the 18 specific head 
and neck scales. The largest difference between groups, 
favouring the intervention group, was for fatigue at 6 
months and for pain and social eating at 12 months. 
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• Control group had a higher score on the physical health 
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patients were given 
NCI publication 
Facing Forward and 
met with nurse and a 





discuss risk of late 
effects and toxicities, 
and screening and 
lifestyle 
recommendations. 
Visit content followed 
treatment summaries 
guidelines by 





















































(p=0.04) at baseline but groups were not significantly 
different at 3 and 6 months. 
• At 3 months, the intervention group scored significantly 
lower (less worry) on the health worry (p=0.01) and health 
worry subscale (p=0.02) of the ASC however, the difference 
did not persist at 6 months. The health worry subscale 
increased (more worry) signiﬁcantly in the control group and 
decreased signiﬁcantly in the intervention group (p = 0.05). 
• At 3 months, the intervention group scored significantly 
lower on the existential negative outlook scale on the IOC 
compared with the control group (p=0.04) however, the 
change from baseline was not significant between groups.  
• Patients with higher physical awareness had higher health 
worry (p = 0.008). 
• A multivariable exploratory linear regression analysis 
controlling for age, stage, ethnicity, education, marital 
status, employment, income, and health literacy confirmed 
the relationship between the intervention and less health 
worry (p=0.04). 
• No difference in total scores or subscale scores between 
the control and intervention groups on the FACIT-TS-PS, 
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No details of nurse's 
qualification or 
experience provided. 
Trained in all aspects 
of the protocol. Care 
started up to 6 




consisted of: an 
information package; 
personalised SCP; 
an individualised 1 
hour nurse-led face-
to-face end of 





common issues and 
healthy lifestyle; and 
telephone follow-up 
at 1, 3, and 7 weeks 





































































• The primary outcome, psychological distress at 2 months 
post baseline, was not significantly different between 
groups. 
• There were no significant differences between groups for: 
psychological distress (6 months); cancer survivor unmet 
needs sub-scales (2 and 6 months); and symptoms and 
functioning QoL sub-scales (2 and 6 months). 
• Intervention group participants were more satisfied with 
care provided than usual care participants, with statistical 
differences between groups on the majority of items. 
Median scores for most items were the same, but 
interquartile ranges indicated that more intervention 
participants “agreed” or “strongly agreed” with item content 
than did usual-care participants. 
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Breast care nurse 
specifically trained 
for the study. Started 
within 6 weeks after 
end of final treatment 













BCN at hospital if 
required. 






















































• Nurse-led group patients had on average 2.4 telephone 
contacts with the BCN and 3.4 visits to the hospital, of 
which one hospital visit conformed to protocol and 2.4 were 
additional visits. Hospital group patients had on average 5.9 
visits to the hospital, of which four visits conformed to 
protocol and 1.9 were additional visits. The mean number of 
general practitioner visits did not differ between groups. 
• Mean health related QoL scores were not significantly 
different between nurse-led and hospital follow-up groups at 
12 months. The 95% conﬁdence interval for the estimated 
difference (positive difference favours nurse-led follow-up) 
between mean HRQoL scores at 12 months after treatment 
was -1.93 – 4.64. 
• HRQoL signiﬁcantly improved over time (p=0.01), but 
without signiﬁcant differences in slope of improvement 
between both follow-up groups (p = 0.41). 
• There was no signiﬁcant difference in health related QoL 
between follow-up with or without EGP. The 95% 
conﬁdence interval for the estimated difference (positive 
difference favours EGP) between mean health related QoL 
scores at 12 months was -3.59–3.00. There was no 
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presented by the 
BCN and a 
psychologist 
consisted of 2 
interactive 2.5 hour 
group sessions for 
patients +/- their 




























• There was no signiﬁcant interaction effect between EGP 
and nurse-led telephone follow-up with respect to health 
related QoL. 
Economic evaluation 
• Hospital follow-up plus EGP yielded most quality-adjusted 
life years (QALY), but was also the most costly follow-up 
strategy of the study.  
• Hospital follow-up plus EGP was not considered to be cost-
effective; nurse-led telephone follow-up plus EGP was the 
preferred follow-up strategy and was conducive to cost 
reductions. 
• However, for patients with high levels of anxiety after 
treatment, hospital follow-up plus EGP was the preferred 
strategy in terms of cost effectiveness. 
• The detailed cost analysis showed that health care costs 
were lower if some ﬁrst year hospital follow-up visits were 
replaced by nurse-led telephone follow-up. This was mostly 
due to reduced costs for visits, concomitant laboratory tests 
and other diagnostics. 
• Mean cost differences from the societal perspective 
between nurse-led telephone follow-up plus EGP and 
current clinical practice (hospital follow-up), were €448 for 1 
year per breast cancer patient. 
Kirshbau
m et. al., 
2017 [45], 
UK 
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Breast care nurse 
role extended to 
advanced 
practitioner. Started 
after surg. and before 
adjuvant RT and 
open access follow-

























• An age factor, but not a group factor, remained in the model 
which best described: depression and anxiety sub- scales 
(HADS); body image, future perspective, sexual functioning, 
systemic therapy side effects, breast symptoms and arm 
symptoms sub- scales (QLQ- BR23); and physical 
functioning, role functioning, emotional functioning, 
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with Breast Cancer" 
of 4 half day 
sessions and 
provided with a 
resource pack. Open 
access to the breast 
surgical services 
telephone helpline 
run by breast cancer 
nurses. No routine 
follow-up; annual 
mammography 
provided with results 
by post and patients 
can return to clinic 
immediately without 













































• Both age and group, plus their interaction, were found to 
significantly improve goodness-of- fit in a model which best 
describes the QLQ- C30 sub- scales: fatigue, nausea and 
vomiting, pain, dyspnoea, insomnia, appetite loss, 
constipation, diarrhoea and financial difficulties. 
• Age was statistically significant with respect to the QLQ- 
BR23 sub- scales sexual functioning, future perspective and 
systematic therapy side effects; and the QLQ- C30 sub- 
scale physical functioning. An increase in age of 1 year was 
associated with an estimated: reduction of 1.01 points on 
the sexual functioning sub- scale; 0.66 points increase on 
the future perspective sub- scale; 0.68 points reduction on 
the systematic therapy side effects sub- scale and a 0.42 
points reduction on the physical functioning sub- scale. 
• The group as a main effect was not statistically significant 
with respect to any sub- scale in which the age-group 
interaction was not included in the final model. The age-
group interaction was statistically significant with respect to 
the QLQ-C30 diarrhoea sub- scale. 
• For all sub-scales except the nausea and vomiting and 
diarrhoea sub- scales (QLQ- C30) which had very low i.e. 
high functionality scores, the majority of model variance 
calculated using the variance partition coefficient occurred 
at the patient level, with relatively low variation in scores 
obtained from the same patient at different times. 
• Patient age was a far more important predictor of sub- scale 
scores than the assigned group. Among younger patients, 
those in the control group had higher functionality, whereas 
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• 102 patients were low-intermediate risk (51 medical follow-
up and 51 nurse-led follow-up) and 67 were high risk (32 
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After the first medical 
follow-up 
appointment at 6 
weeks post RT 
completion, monthly 
nurse follow up 





patients were asked 
questions about well-
being, urinary and 
bowel function, 




advice provided and 
ongoing follow-up 
plan documented. 
CNC referred back to 


























• Low-intermediate risk patients who received nurse-led care 
appeared to report higher satisfaction than low-intermediate 
risk medical follow-up patients (p=0.051). This was not 
statistically significant in a multivariate linear regression 
which controlled for cohort effect. Therefore, men with low 
risk disease, followed up by nurse-led telephone service, 
were as satisﬁed with their care as the equivalent group 
receiving conventional medical follow up. 
• 11% of low-intermediate risk men who received nurse-led 
care and 10% of low-intermediate risk men who received 
medical follow-up were distressed (≥5/10 on distress 
thermometer) (not significantly different, including when 
cohort effect controlled in linear regression). 
• There were no statistical signiﬁcant differences between the 
risk groups across both cohorts on any of the EPIC scales. 
• Men in the low-moderate risk groups reported impact of 
urinary, bowel and hormonal function similar to that 
published in other studies. Sexual domain scores were 
much lower in this sample than other studies. 
• Regardless of risk group, the majority of men had good or 
very good bladder function and minimal urinary 
incontinence, bowel dysfunction and sexual dysfunction. 
• The high-risk groups demonstrated more marked sexual 
dysfunction and more symptoms in the hormone domain. 
Li et. al., 









Starting from 7 days 
post-surgery and 



























• The intervention group at 6 months follow-up compared with 
baseline (within groups) had significantly increased QoL 
(p<0.001), cohesion (p<0.001), adaptability (p<0.001) and 
female sexual function index (p<0.001). The control group 
experienced a significant decrease in the female sexual 
function index over the same period (p<0.001). 
• The following QoL subscales were significantly increased 
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education of family 




follow-up and home 










































up compared with baseline: social/familial (p=0.031), 
emotional (p<0.001) and cervical cancer (p<0.001). 
• Change scores (follow-up minus baseline) at 6 months were 
significantly different between groups with a greater positive 
change in the intervention group for the following: overall 
QoL (p<0.001) and emotional (p<0.001), social (p<0.001) 
and cervical (p<0.001) subscales; cohesion (p<0.001) and 
adaptability (p<0.001) subscales of family function 
(p<0.001); and female sexual function index (p<0.001). The 
QoL functional subscale change score was negative in the 
intervention group at 6 months and was significantly 
different between groups (p=0.009). 
• There was no significant change in the control group in the 
proportion of family function change scores from baseline to 
follow-up categorised as extreme low, extreme high, 
balanced, and middle-range. There was a significant 
change in the intervention group with an increased 
proportion of extreme high and balanced types at follow-up 
and decreased middle-range types. 
Malmstro










Nurse specialised in 
postoperative 
oesophageal cancer 
care. Started at 
discharge until 6 
months after 




















• The intervention group had significantly worse dyspnoea 
symptoms (QLQ-C30) during 6 months follow-up (p=0.041). 
There were no other significant differences between groups 
for functional or symptom QoL scales or diagnosis-specific 
QoL scales. 
• At discharge, the intervention group scored significantly 
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care and life after 
surgery and a follow-
up plan. Proactive 
nurse telephone 
follow-up depending 
on individual patient 
needs (average 16 
calls). 
does not 











































'written information' scale. 
• During 6 months follow-up, the intervention group was 
significantly more satisfied than the control group 
concerning information about 'things to do to help yourself' 
(p<0.001), written information (p<0.001) and the global 
information score (p<0.001). 
• During the 6 months follow-up, the control group was 
significantly more likely to 'wish to receive more info' 
(p<0.001) and at baseline, 'wish to have received less info' 
(p<0.007). 
• During 6 months follow-up, there were no significant 
differences in the number of health care contacts (hospital 
care register), private health care contacts (private care 
register) and surgery related contacts between the groups. 
There were no significant differences between groups in 
diary recorded contacts in the first 2 or first 4 weeks. 
• During the follow-up period (6 months), tumour recurrence 
occurred in 24.4% of the intervention group and 22.0% of 














Oncology APN and, 























• 73% of patients were newly diagnosed and 27% had 
recurrent disease. 
• At baseline, the nursing intervention group reported 
significantly poorer QoL in relation to depressive symptoms 
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consisted of 2 
contacts per week for 
1 month then 2 per 
month up to 6 
months by home and 
clinic visits and 




























































However, baseline scores for both groups were adjusted in 
further model testing. 
• In all models, QoL improved over time for the total sample 
(all p<0.0001), except for the SF-12 mental subscale. 
• The rate of improvement in uncertainty was signiﬁcantly 
greater for the nursing intervention only (p=0.0006). 
However, the attention control group appeared to perform 
better over time in depressive symptoms (CES-D; p=0.003), 
symptom distress (SDS; p=0.0021), and the physical QoL 
subscale (SF-12; p=0.0019). 
• Treating the PCLN component as a higher dose of the 
intervention showed there was a significantly better 
improvement in uncertainty (MUIS; p<0.0001) and the 
mental QoL subscale (Sf-12; p=0.0023), and less 
improvement over time for depressive symptoms (CES-D; 
p=0.0033). 
• Treating the PCLN as a separate component found that it 
significantly increased the rate of improvement over time for 
uncertainty (p=0.0181), symptom distress (p<0.0001), and 
mental (p<0.0001) and physical QoL (p<0.0001). There was 
no significant effect of the PCLN on depressive symptoms 
over time. 
• Co-variates which remained significant in the model building 
process demonstrated that patients who were younger than 
60 years, educated at a high school level or less, married, 
had fewer comorbidities, and newly diagnosed with cancer 
had less improvements on QoL outcomes over time. 
Healthcare Utilization 
• Patients who received the nursing intervention had fewer 
primary care visits in 6 months after surgery (2.75 ± 2.03 vs 
3.59 ± 4.66). Regression analysis confirmed patients who 
received the nursing intervention had significantly less 
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least 1 month of 
treatment completion 
(excluding HT) and 
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• Overall QoL in the control group was significantly improved 
from baseline to 6 months (p=0.016), between 3 and 6 
months (p=0.004) but was not improved from baseline to 3 
months (p=0.522). Overall QoL in the intervention group 
was significantly improved from baseline at 3 (p<0.001) and 
at 6 months (p<0.001). The intervention group, compared 
with the control group, had a significantly better 
improvement from baseline in overall QoL at 3 months 
(p<0.001) and at 6 months (p<0.001). 
• No significant interaction terms were found between the 
intervention and other covariates, including time, in 
Generalised Estimating Equation (GEE) models.  
• GEE analysis showed significant differences in overall QOL 
and psychological (p=0.0083) and social well-being 
(p=0.0083) domains between groups. There were no 
significant differences in physical or spiritual well-being 
between groups.  
Rural Analysis 
• There was a significant improvement in mean overall QOL 
score in the BCEI intervention group compared with the 
wait-control arm over time, adjusting for baseline. The 
adjusted difference in mean overall QoL scores between 
experimental and control arms from 3 months to 6 months 
was estimated at -0.429 (SE, 0.18; p=0.013). 
• Significant improvement in mean psychological QOL score 
in the BCEI intervention group compared with the wait-
control arm over time, adjusting for baseline. The adjusted 
difference in mean psychological QoL scores between 
experimental and control arms from 3 months to 6 months 
was estimated at -0.545 (SE, 0.26; p=0.048). 
• The beneficial effect of the BCEI intervention on overall 
QOL and psychological QOL score was maintained over 
time; there was no significant change in scores between 3 
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Trained in diagnosis 
and treatment of 
oesophageal and 




legal issues and 
aspects of follow-up. 
Three weeks after 
hospital discharge 
following intentionally 
curative surgery, one 
visit at the outpatient 
clinic occurred then 
nurse-led follow-up 
home visits were 
scheduled at 6 
weeks, and 3, 6, 9 
































































• Standard follow-up care visits were significantly shorter than 
visits in the nurse-led follow-up group (11 versus 43 
minutes; p<0.01). 
• The nurse referred 39% of patients to the outpatient clinic 
for medical evaluation of specific symptoms and medical 
problems. 
• A similar proportion of patients in both groups developed 
loco regional tumour and/or metastases at 1 year survival 
(p=0.50). 
• Mean body weight of patients of the standard follow-up 
group significantly deteriorated during the first year after 
surgery (p=0.04); whereas mean body weight in the nurse-
led follow-up group remained stable or slightly increased 
(p=0.19). 
• No significant differences were found in dysphagia scores 
between the two groups; similar proportions in each group 
experienced dysphagia (score 2-4) which required one or 
more dilations of a benign anastomotic stricture. 
• No significant differences in other physical problems 
between groups. 
• Improvement for all patients in health status (EQ-5D Index, 
p<0.001) and self-rated health on a vertical visual analogue 
scale (EQ-VAS, p<0.001). 
• A significant improvement was found in the dysphagia, 
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weight and the ability 










fatigue, physical, role, cognitive and social functioning 
scales, and in global health (QLQ-C30). 
• No significant differences in mean QoL (QLQ-C30) and 
oesophageal cancer-specific QoL (QLQ-OES18) scale 
scores between groups over time. 
• Spouses of patients in the nurse-led follow-up group were 
significantly more satisfied with the follow-up visits than 
those in the standard follow-up group (p=0.03); mean 
patient satisfaction was higher in the nurse-led group 
compared with the standard care group but the difference 
between groups was not significant (p=0.14). 
• Patients and spouses in the standard follow-up group more 
often indicated that visits did not fulfil their expectations 
(p=0.04 and p=0.03, respectively) in terms of a systematic 
follow-up schedule with diagnostic tests and/or procedures 
for the early detection of recurrent malignancy. 
• Patients and spouses of the nurse-led follow-up group more 
frequently received advice regarding disease management 
(p=0.04 and p=0.03, respectively). 
• Spouses of the nurse-led follow-up group were more 
satisfied they had an opportunity to ask questions (p=0.06). 
Economic analysis 
• Cost of nurse-led follow-up visits were significantly less than 
standard follow-up (€234 vs €503, p<0.001). 
• Significantly more patients in the nurse-led follow-up group 
attended all 5 follow-up visits compared with standard 
follow-up (82% versus 60% respectively, p=0.02) 
• Mean hospital stay was significantly longer for standard 
follow-up care (17.8 days versus 8.9 days, p=0.07). 
• Intramural care costs were the highest cost in both follow-
up types but were not significantly different between types. 
Costs were similar between follow-up types for diagnostic 
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• Total costs were lower for nurse-led care compared with 
standard follow-up care (€2592 versus €3798) but due to 
large variation were not statistically different (p=0.11). 
• Disregarding QoL effects, there was a 91% probability that 
nurse-led follow-up was cost-effective compared with 
standard follow-up. 
• At 4 months, there was a 98% probability that nurse-led 
follow-up was cost effective compared with standard follow-
up at €500 per point improvement in EQ-VAS (based on a 
mean improvement of 14 versus 9 points for the nurse-led 
and standard care groups respectively). 
• At 13 months EQ-VAS scores had reduced slightly in the 
nurse-led follow-up group and had remained stable in the 
standard follow-up group (mean improvement 11 versus 9 
points, respectively) therefore, there was a probability of 
76% probability that nurse-led follow-up was cost effective 
compared with standard follow-up at €4000 or more for a 
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• At 13 months follow-up, significantly more health education 
participants compared with emotional expression 
participants agreed they would have liked to see their nurse 
in the past 4-5 months (48% versus 32%, p=0.035). 
• There were differences between the experimental groups in 
terms of therapy process: health education sessions were a 
few minutes longer than emotional expression sessions; the 
content of sessions 2-5 differed, for example, significantly 
more health education patients discussed treatment side 
effects (p<0.04) and significantly more emotional 
expression patients discussed fears concerning recurrence 
(p<0.07); and overall, more emotional expression 
participants expressed emotionality whereas the groups did 
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• There was a significant effect of time (3x2 ANOVAS) 
between post-test and 13 months follow-up for total QoL 
and the emotional well-being sub-scale (FACT-G), and 
additional breast cancer specific concerns for all women. 
There were no significant effects of experimental group on 
outcome nor any interaction effects between experimental 
group and time; all groups improved over the 13 month 
period in terms of QoL. 
• Significant time effects (3x2 ANOVAS) for overall mood, 
and for depression, anger, and fatigue subscales (POMS) 
for all women. No significant effects of experimental group 
on outcome nor any interaction effects between group and 
time; all groups improved over the 13 month period in terms 
of overall mood. 
• Significant time effects (3x2 ANOVAS) for avoidant coping 
and perceived stress with all women demonstrating 
improvement from post-test to 13 month follow-up. Health 
education participants reported significantly less perceived 
stress than women in the emotional expression or control 
groups (p=0.05).No significant between groups effects in 
relation to avoidant coping nor time-group interaction effects 
for either coping or perceived stress. 
• Significant time effects (3x2 ANOVAS) for all participants’ 
confidence in their knowledge to prevent lymphedema 
(p=0.005). Significantly more health education participants 
reported more ways to deal with lymphedema (p=0.004). 
There were no other significant time or experimental group 
effects nor were there any interaction effects. 
• Significant improvements over time (3x2 ANOVAS) for all 
participants in intrusive thoughts (p<0.001), control over 
cancer (p=0.033) and social constraints (p=0.013). No 
significant between group or interaction effects. 
• No significant moderators (age, education or cancer stage) 
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stress, and avoidant coping) by experimental group 
(ANCOVAS). Across the sample, age produced a main 
effect for avoidant coping with younger women engaging in 
more avoidance over time (p=0.02).  
• Carers' perceptions of the patient's QoL were significantly 
correlated with participants' responses (rs>0.40) and carers 
perceived greater emotional distress for the patient than 
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maxillofacial and the 
otorhinolaryngology 
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One year effect 
• At 12 months post treatment, intention to treat analysis 
revealed a significant decrease in depression (CES-D) in 
the intervention group compared with control. In the 
depressive subgroup of patients (CES-D ≥12), the 
intervention group had a significant decrease in depressive 
symptoms at 12 months (p<0.05). When between group 
differences were adjusted for baseline education level in 
this subgroup, depressive symptoms decreased 
significantly in the intervention group at 12 months from 
19.0 (S.D.=7.3) to 13.8 (S.D.=10.1) but increased in the 
control from 21.0 (S.D.=8.3) to 22.0 (S.D.=12.6). 
• Compared with the control group, the intervention group 
had significantly better reduction in physical symptoms from 
baseline for: pain, swallowing and opening mouth (p<0.05). 
Symptoms of dry mouth (not significant) and coughing 
(p<0.05) were increased in the intervention group. In the 
depressive subgroup of patients (CES-D ≥12), the 
intervention group had a significantly better reduction in 
physical symptoms of opening mouth (p<0.05). 
• Depressive symptoms were significantly correlated with all 
head and neck cancer related symptoms at baseline and 12 
months. Also, depressive symptoms were significantly 
correlated with changes from baseline to 12 months after 
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functioning in six life 
domains; providing 
the Adjustment to 







advice, if indicated; 
and referring patients 
to psychological 
aftercare, if indicated. 






















• Between group differences 12 months after treatment 
demonstrated a significant improvement (referenced to 
baseline) in the intervention group for the following QLQ-
C30 items: physical and emotional functioning and 
diminished pain (p<0.05). Significant between group 
differences in favour of the intervention group at 18 months 
were found for global QoL, role and emotional functioning 
and pain (p<0.05). At 24 months, the intervention group's 
emotional functioning and fatigue were significantly better 
compared with the control group (p<0.05). 
• Between group differences for QLQ H&N35 items at 12 
months demonstrated a significant improvement 
(referenced to baseline) in the intervention group compared 
with the control for: pain, swallowing, social contact and 
mouth opening (p<0.05); these significant effects were 
sustained to 18 months, apart from social contact which 
was not significantly different. At 12 months, the 
intervention group reported significantly more problems with 
coughing (p<0.05) than the control group. At 24 months, 
there were no between group differences in any head and 
neck cancer related symptoms. 
• Depressive symptoms (CES-D) were significantly 
diminished (p<0.05) at 12 and 18 months in the intervention 
group compared with the control. At 24 months, depressive 
symptoms in the intervention group were lower, but were 
not significantly different compared with the control. 
Moderators of psychosocial effects 
• At 12 months, linear regression analysis identified the 
following moderators of the effect of the intervention in the 
full-case analysis (n=146; completed baseline and 12 
month assessments): marital status (b=−6.75, p=0.04), 
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(b=−0.14, p=0.02), and social functioning (b=−0.13, 
p=0.04).  
• Post-hoc between group comparisons (n=146) found a 
significant difference in favour of: married or de facto 
patients compared with single patients (b=−4.25, p=0.01); 
and patients with low (-1 S.D.) baseline global QoL 
(b=−5.65, p=0.01), emotional functioning (b=−5.99, p=0.00), 
and social functioning (b=−5.41, p=0.01) compared with 
patients with mean or high (+1 S.D.) baseline scores. That 
is, patients who were married/de facto, and patients with 
low baseline scores on global QoL, emotional functioning, 
and social functioning responded better to the intervention 
than patients with high scores and who were single. 
• In the intention-to-treat analyses (n=179; baseline and 3 
months completed, 12 month data imputed), emotional 
functioning (b=−0.14, p=0.02) and social functioning 
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quality of life 
instrument;  
Randomised controlled trial 
• No significant differences between groups at 3 or 6 months 
in: overall experience of cancer care coordination score, 
global assessment of care coordination or quality of care; 
unmet needs (SCNS-SF34); distress; overall QoL or any 
subscales (FACT-C); unplanned readmissions; emergency 
room presentations and proportion of Dukes C colon cancer 
patients receiving adjuvant chemotherapy. 
• Median scores (SCNS-SF34) were not significantly different 
between groups for health system and information needs 
and patient care and support needs at 3 and 6 months. 
• In terms of the nurse intervention, the majority of 
intervention patients very much agreed: the nurse was 
caring and understanding; the assistance was satisfactory; 
understandable and helpful information was provided; the 
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days 3 and 10 and 
then at 1, 3 and 6 
months. CONNECT 
aims to improve 
patients’ ability to 
navigate the health 
system for clinical 
and supportive care, 
provide information 
and emotional 
support, and improve 
patients’ cancer-
related QOL. Each 
call structured using 
a standardised 
checklist that covers 





supportive care, and 
rehabilitation/follow-





to the nature and 
severity of the need 

























improved confidence to self-manage health. Few patients 
(<11%) very much agreed that the nurse did not have a 
thorough understanding of their medical conditions or did 
not know about support services. 
• Interviews with intervention patients (n=29) identified three 
groups of patients: patients who felt that the intervention did 
not influence their recovery as their local health care team 
provided information and support; a group who felt they did 
not need the intervention because their recovery was 
straightforward and uneventful; and a third group who had 
acute concerns and perceived the intervention was an 
important service that assisted them in their postoperative 
recovery. 
Abbreviations used: activities of daily living (ADL), Advanced Practice Nurse (APN), chemotherapy (chemo.), confidence interval (CI), Clinical Nurse Coordinator (CNC), 
consent rate (CR), control (C), educational group program (EGP), European Organization of Research and Treatment of Cancer (EORTC), Generalised Estimating Equation 
  
(GEE), general practitioner (GP), hormone therapy (HT), intervention (I), not provided (NP), Quality of Life Questionnaire (QLQ), Quality of Life (QoL), RCT (RCT), registered 
nurse (RN), response rate (RR), radiation therapy (RT), survivorship care plan (SCP), standard deviation (S.D.), treatment summary (TS), surgery (surg.) 
 
 
